Kurosh Ameri

Kurosh Ameri is a seasoned scientific professional with extensive experience in cancer therapeutics and molecular oncology. As the Founder and Chief Scientific Officer of Soley Therapeutics since November 2020, Kurosh also served as Acting CEO from December 2020 to July 2022. Prior to this, Kurosh held significant positions at the University of California, San Francisco, including Associate Director of the Translational Cardiac Stem Cell Program and Professional Research roles from January 2010 to November 2020. Kurosh's research background includes a Senior Research Scholar position at Stanford University School of Medicine and a EU-young scientist role at Ludwig Maximillians University of Munich, focusing on independent research in cancer therapeutics and gene therapy. Kurosh began a career in cancer therapy and oxygen sensing during the postdoctoral tenure at the University of Oxford, supported by a Ph.D. in Pathology-Molecular Oncology from the University of Oxford/University of Sheffield and a BSc with Honors in Molecular Biology from the University of Glasgow.